+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Hemorrhoid Treatment Devices Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

  • PDF Icon


  • 110 Pages
  • August 2022
  • Region: Global
  • Mordor Intelligence
  • ID: 4986964
UP TO OFF until Mar 31st 2024
The Hemorrhoid Treatment Devices Market is expected to register a CAGR of 4.7% during the forecast period.

The COVID-19 pandemic is an unprecedented health concern and has adversely affected communities, industries, businesses, and lives worldwide. It is still affected by the rise of new variants of the virus. The rising COVID-19 cases across the globe are having a profound impact on the market. Various research studies have provided insight into Covid's effect on the market. For instance, in October 2020, a research study published titled "Impact of COVID-19 Quarantine on Advanced Hemorrhoidal Disease and the Role of Telemedicine in Patient Management" stated that COVID-19-related delays are linked to a deterioration of hemorrhoidal symptoms and patients' well-being. Weight and lifestyle changes were deemed critical factors in determining disease severity. Hence, the lockdown and other social impacts hurt the market. However, in the long term, the market will grow.

A hemorrhoid is an abnormal mass of engorged and dilated blood vessels in swollen tissue that occurs internally in the anal canal or externally around the anus that may be characterized by bleeding, pain, or itching. Hemorrhoids can develop inside the rectum (internal hemorrhoids) or under the skin around the anus (external hemorrhoids). Hemorrhoids have several causes, but often the cause is still unknown. Some effective treatment options are available for hemorrhoids, but most people get relief with home treatments and lifestyle changes.

Product launches provide new and innovative devices which increase efficiency in the market. For instance, in February 2019, Organization de Scalene launched Cryocure, an affordable medical device to treat piles without surgery. Cryocure uses advanced cryogenic physics and polymolecular technology to treat hemorrhoid-affected (Piles) patients in 15 days without surgery. Such product launches reduce complications and further boost the demand of the market.

Research studies are another factor in the growth of the market. For instance, in April 2021, a research study published titled "Prevalence and associated factors of hemorrhoids among adult patients visiting the surgical outpatient department in the University of Gondar Comprehensive Specialized Hospital, Northwest Ethiopia" stated that the overall prevalence of hemorrhoids was high and its prevalence was higher in male subjects. Constipation and being overweight were found to increase the odds of having hemorrhoids. Screening for early identification and intervention of hemorrhoids, especially for risk groups, is better practiced by health professionals. Hence, the increasing diagnosis will lead to high treatment and increasing market growth in the future.

However, the availability of several drugs as an alternate treatment option will hinder market growth in the future.

Key Market Trends

Band Ligators Segment is Expected to Hold a Major Market Share in the Hemorrhoid Treatment Devices Market

For internal and severe forms of hemorrhoids, band ligators offer better solutions than others in terms of outcomes and effectiveness in treatment. According to a study published in the International Surgery Journal, hemorrhoid is one of the most common disorders among young adults. It is estimated that over 50% of people suffer from piles before they reach the age of 50.

Various research studies have provided insight into the market. For instance, in March 2021, a research study titled "Rubber band ligation versus haemorrhoidectomy for the treatment of grade II-III hemorrhoids: a systematic review and meta-analysis of randomized controlled trials" stated that haemorrhoidectomy seems to provide better symptom control, but at the cost of more pain and complications. Haemorrhoidectomy offers better symptom control than rubber band ligation in patients with grade II-III hemorrhoids but is accompanied by more postoperative pain and complications. Such studies will increase the market growth by providing new hemorrhoid treatment methods.

Band Ligators segment holds a significant market share in the hemorrhoid treatment devices market. It is anticipated to show a similar trend over the forecast period due to a lower risk of pain than surgical treatments of hemorrhoids and a shorter recovery period.

North America is Expected to Hold a Significant Share in the Market and Expected to do Same in the Forecast Period

North America is expected to hold a significant market share in the hemorrhoid treatment devices market due to increasing awareness about the availability of advanced treatment options, better reimbursements policies, and fast commercialization of novel products in this region. In February 2019, an article titled "Epidemiology of Hemorrhoids" stated that according to the HD Treatment Center in North Carolina, an estimated 10.4 million and 1 million new cases of hemorrhoids occur in the United States each year. Among them, 10% to 20% of those new cases require surgery. In addition, around half of Americans develop hemorrhoids at the age of 50 years, and only a tiny proportion of those people seek therapy.

Band ligation is one of the most frequently used methods in treating hemorrhagic internal hemorrhoidal disease. Product launches are one of the factors for the growth of the market. For instance, in March 2020, Micro-Tech Endoscopy launched a new product in their hemostasis portfolio with the In-Sight Multi-Band Ligator. In-Sight was designed for the office-based, non-endoscopic treatment of grade I, II, and III internal hemorrhoids.

Many studies have shown that these methods are safe to use. For instance, in February 2020, a clinical trial titled "The Effect of Rubber Band Ligation in Bleeding Internal Hemorrhoids" studied the effect of rubber band ligation. Under this, the investigators aimed to investigate the benefit of adding rubber band ligation to treatment in hemorrhagic internal hemorrhoidal disease treated with the anti hemorrhoidal drug. Such clinical trials will improve the market growth.

Moreover, technological advancements in hemorrhoid treatment devices and well-established healthcare infrastructure are also considerably fueling the regional market's growth.

Competitive Landscape

The Hemorrhoid Treatment Devices Market is fragmented in competition and consists of several major players. In terms of market share, a few major players dominate the market. Some companies currently dominating the market are Boston Scientific Corporation, Medtronic Plc, Cook Medical, DePuy Synthes (Johnson & Johnson), Integra LifeSciences Corporation, CONMED Corporation, Medline Industries, Inc, Surkon Medical Co., Ltd, Sklar Surgical Instruments and Privi Medical.

Additional Benefits:

  • The market estimate (ME) sheet in Excel format
  • 3 months of analyst support

This product will be delivered within 2 business days.

Table of Contents

1.1 Study Assumptions and Market Definition
1.2 Scope of the Study
4.1 Market Overview
4.2 Market Drivers
4.2.1 Rise in Prevalence of Hemorrhoids
4.2.2 Technological Advancements in Hemorrhoid Treatment Devices
4.3 Market Restraints
4.3.1 Availability of Several Drugs as an Alternate Treatment Option
4.4 Porter's Five Force Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5 MARKET SEGMENTATION (Market Size by Value - USD million)
5.1 By Product Type
5.1.1 Band Ligators
5.1.2 Bipolar Probes
5.1.3 Laser Probes
5.1.4 Cryotherapy Devices
5.1.5 Infrared Coagulators
5.1.6 Sclerotherapy Injectors
5.1.7 Others
5.2 Geography
5.2.1 North America United States Canada Mexico
5.2.2 Europe Germany United Kingdom France Italy Spain Rest of Europe
5.2.3 Asia-Pacific China Japan India Australia South Korea Rest of Asia-Pacific
5.2.4 Middle-East and Africa GCC South Africa Rest of Middle-East and Africa
5.2.5 South America Brazil Argentina Rest of South America
6.1 Company Profiles
6.1.1 A.M.I. GmbH
6.1.2 Boston Scientific Corporation
6.1.3 CONMED Corporation
6.1.4 Cook Medical
6.1.5 DePuy Synthes (Johnson & Johnson)
6.1.6 Integra LifeSciences Corporation
6.1.7 Medline Industries, Inc
6.1.8 Medtronic Plc
6.1.9 obp Surgical Corporation
6.1.10 Privi Medical
6.1.11 Sklar Surgical Instruments
6.1.12 Surkon Medical Co., Ltd

Companies Mentioned

A selection of companies mentioned in this report includes:

  • A.M.I. GmbH
  • Boston Scientific Corporation
  • CONMED Corporation
  • Cook Medical
  • DePuy Synthes (Johnson & Johnson)
  • Integra LifeSciences Corporation
  • Medline Industries, Inc
  • Medtronic Plc
  • obp Surgical Corporation
  • Privi Medical
  • Sklar Surgical Instruments
  • Surkon Medical Co., Ltd